# Globe Life Inc.: overview

GL · NYSE · CIK 320335 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gl.md) · [Financials](/companies/gl/financials.md) · [Filings](/companies/gl/filings.md) · [Insiders](/companies/gl/insiders.md)

Latest reported revenue: [$1.60bn](/filings/0000320335-26-000216.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0000320335-26-000216).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,455](/filings/0000320335-25-000064.md) | [1,466 d](/filings/0000320335-26-000090.md) | [1,480](/filings/0000320335-26-000169.md) | [1,481](/filings/0000320335-26-000216.md) | [1,513](/filings/0000320335-25-000064.md) | [1,520 d](/filings/0000320335-26-000090.md) | [1,560](/filings/0000320335-26-000169.md) | [1,600](/filings/0000320335-26-000216.md) |
| Gross margin | % | [26.1%](/filings/0000320335-24-000060.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [26.3%](/filings/0000320335-24-000060.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [20.8%](/filings/0000320335-25-000064.md) | [17.4% d](/filings/0000320335-26-000090.md) | [17.2%](/filings/0000320335-26-000169.md) | [17.1%](/filings/0000320335-26-000216.md) | [25.6%](/filings/0000320335-25-000064.md) | [17.5% d](/filings/0000320335-26-000090.md) | [17.3%](/filings/0000320335-26-000169.md) | [18.0%](/filings/0000320335-26-000216.md) |
| Diluted EPS | $ per share | [3.44](/filings/0000320335-25-000064.md) | not reported | [3.01](/filings/0000320335-26-000169.md) | [3.05](/filings/0000320335-26-000216.md) | [4.73](/filings/0000320335-25-000064.md) | not reported | [3.39](/filings/0000320335-26-000169.md) | [3.65](/filings/0000320335-26-000216.md) |
| Free cash flow | $m | [311 d](/filings/0000320335-25-000064.md) | [322 d](/filings/0000320335-26-000090.md) | [420](/filings/0000320335-26-000169.md) | [295 d](/filings/0000320335-26-000216.md) | [209 d](/filings/0000320335-25-000064.md) | [330 d](/filings/0000320335-26-000090.md) | [396](/filings/0000320335-26-000169.md) | [298 d](/filings/0000320335-26-000216.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,112](/filings/0000320335-24-000006.md) | [5,227](/filings/0000320335-25-000013.md) | [5,448](/filings/0000320335-26-000090.md) | [5,778](/filings/0000320335-26-000090.md) | [5,994](/filings/0000320335-26-000090.md) |
| Gross margin | % | [23.8%](/filings/0000320335-24-000006.md) | [22.6%](/filings/0000320335-24-000006.md) | [23.1%](/filings/0000320335-24-000006.md) | not reported | not reported |
| Operating margin | % | [24.0%](/filings/0000320335-24-000006.md) | [22.7%](/filings/0000320335-24-000006.md) | [23.2%](/filings/0000320335-24-000006.md) | not reported | not reported |
| Net margin | % | [20.2%](/filings/0000320335-24-000006.md) | [17.1%](/filings/0000320335-25-000013.md) | [17.8%](/filings/0000320335-26-000090.md) | [18.5%](/filings/0000320335-26-000090.md) | [19.4%](/filings/0000320335-26-000090.md) |
| Diluted EPS | $ per share | [9.99](/filings/0000320335-24-000006.md) | [9.04](/filings/0000320335-25-000013.md) | [10.07](/filings/0000320335-26-000090.md) | [11.94](/filings/0000320335-26-000090.md) | [14.07](/filings/0000320335-26-000090.md) |
| Free cash flow | $m | [1,399](/filings/0000320335-24-000006.md) | [1,394](/filings/0000320335-25-000013.md) | [1,433](/filings/0000320335-26-000090.md) | [1,331](/filings/0000320335-26-000090.md) | [1,254](/filings/0000320335-26-000090.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gl/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-23 | [Majors Michael Clay](/insiders/1426922.md) | EVP - Chief Strategy Officer, Officer | Sale (S) | 14,377 | $154.4759 | $2.2m | [Form 4](/filings/0000320335-26-000226.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $987.9m | 5,528,883 |  | Reduced −13,648 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $907.8m | 5,080,734 |  | Reduced −69,258 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $825.4m | 4,619,219 |  | Added +602,869 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $747.2m | 4,181,598 |  | Reduced −72,505 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $667.4m | 3,735,409 |  | Added +76,745 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $500.4m | 2,804,413 |  | Added +75,079 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $427.7m | 2,393,372 |  | Added +40,180 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $346.7m | 1,940,584 |  | Added +8,706 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $270.9m | 1,515,987 |  | Added +318,085 |
| [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $267.4m | 1,496,640 |  | Reduced −2,207 |

## Recent filings

[All 2,286 filings](/companies/gl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 16:39 ET | [8-K](/filings/0000320335-26-000224.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000320335-26-000224 |
| 2026-08-07 | 16:33 ET | [8-K](/filings/0000320335-26-000218.md) | 5.02 Departure or appointment of officers or directors | 0000320335-26-000218 |
| 2026-08-05 | 16:41 ET | [10-Q](/filings/0000320335-26-000216.md) | Quarterly report, period 2026-06-30 | 0000320335-26-000216 |
| 2026-07-22 | 16:34 ET | [8-K](/filings/0000320335-26-000203.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000320335-26-000203 |
| 2026-06-29 | 17:26 ET | [8-K](/filings/0000320335-26-000198.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000320335-26-000198 |
| 2026-05-07 | 16:32 ET | [10-Q](/filings/0000320335-26-000169.md) | Quarterly report, period 2026-03-31 | 0000320335-26-000169 |
| 2026-05-04 | 12:57 ET | [8-K](/filings/0000320335-26-000160.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000320335-26-000160 |
| 2026-04-22 | 16:44 ET | [8-K](/filings/0000320335-26-000143.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000320335-26-000143 |
| 2026-03-19 | 18:16 ET | [DEF 14A](/filings/0000320335-26-000135.md) | Proxy statement, period 2025-12-31 | 0000320335-26-000135 |
| 2026-02-27 | 16:54 ET | [8-K](/filings/0000320335-26-000105.md) | 5.02 Departure or appointment of officers or directors | 0000320335-26-000105 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000320335-26-000090.md), filed Feb 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 320335
- Tickers: GL, GL-PD
- Exchange: NYSE
- SIC code: 6311 Life Insurance
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 15:15 ET. No prices; not investment advice.